{"success":true,"data":{"pressRelease":{"id":"3158","rtpr_id":"nACSl8llLa","ticker":"PMI","exchange":"NYSE American","all_tickers":["PMI"],"title":"Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Picard Medical, Inc. (PMI) and Encourages Stockholders to Learn More About the Investigation","author":"ACCESSWIRE","published_at":"2026-04-21T15:00:01.597Z","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April\n21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential\nclaims on behalf of purchasers of Picard Medical, Inc. (\"Picard Medical\" or\n\"the Company\") (NYSE:PMI). Investors who purchased Picard Medical securities\nprior to September 2, 2025, and continue to hold to the present, are\nencouraged to obtain additional information and assist the investigation by\nvisiting the firm's site: bgandg.com/PMI.\n(https://bgandg.com/PMI/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=PMI)\n(https://app.accessnewswire.com/imagelibrary/b762af47-9007-4583-95e3-73cefb190a68/bronstein-gewirtz-and-grossman-llc.png)\nPicard Medical Investigation Details\n\nThe investigation concerns whether Picard Medical and certain of its officers\nand/or directors have engaged in corporate wrongdoing.\n\nWhat's Next for Picard Medical Investors?\n\nIf you are aware of any facts relating to this investigation or purchased\nPicard Medical shares, you can assist this investigation by visiting the\nfirm's site: bgandg.com/PMI\n(https://bgandg.com/PMI/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=PMI).\nYou can also contact Peretz Bronstein or his client relations manager, Nathan\nMiller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911 (tel:+9175900911)\n\nNo Cost to Picard Medical Investors\n\nWe, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions\non a contingency fee basis. That means we will ask the court to reimburse us\nfor out-of-pocket expenses and attorneys' fees, usually a percentage of the\ntotal recovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Picard Medical Securities\nInvestigation?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide.\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1157719)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSl8llLa","title":"Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Picard Medical, Inc. (PMI) and Encourages Stockholders to Learn More About the Investigation","author":"ACCESSWIRE","ticker":"PMI","created":"2026-04-21T15:00:01.597Z","tickers":["PMI"],"exchange":"NYSE American","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April\n21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential\nclaims on behalf of purchasers of Picard Medical, Inc. (\"Picard Medical\" or\n\"the Company\") (NYSE:PMI). Investors who purchased Picard Medical securities\nprior to September 2, 2025, and continue to hold to the present, are\nencouraged to obtain additional information and assist the investigation by\nvisiting the firm's site: bgandg.com/PMI.\n(https://bgandg.com/PMI/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=PMI)\n(https://app.accessnewswire.com/imagelibrary/b762af47-9007-4583-95e3-73cefb190a68/bronstein-gewirtz-and-grossman-llc.png)\nPicard Medical Investigation Details\n\nThe investigation concerns whether Picard Medical and certain of its officers\nand/or directors have engaged in corporate wrongdoing.\n\nWhat's Next for Picard Medical Investors?\n\nIf you are aware of any facts relating to this investigation or purchased\nPicard Medical shares, you can assist this investigation by visiting the\nfirm's site: bgandg.com/PMI\n(https://bgandg.com/PMI/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=PMI).\nYou can also contact Peretz Bronstein or his client relations manager, Nathan\nMiller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911 (tel:+9175900911)\n\nNo Cost to Picard Medical Investors\n\nWe, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions\non a contingency fee basis. That means we will ask the court to reimburse us\nfor out-of-pocket expenses and attorneys' fees, usually a percentage of the\ntotal recovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Picard Medical Securities\nInvestigation?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide.\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1157719)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-04-21T15:00:01.635075926Z","server_sent_at_ms":1776783601635},"received_at":"2026-04-21T15:00:01.696Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1157719"},"analysis":{"id":"2079","press_release_id":"3158","analysis_json":{"industry":{"label":"Health Care Equipment & Services","sector":"Health Care"},"redFlags":["investigation into corporate wrongdoing","potential securities fraud allegations"],"eventType":"legal_litigation","narrative":"Law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential claims against Picard Medical concerning possible corporate wrongdoing.\n\nThe investigation specifically targets investors who purchased Picard Medical securities prior to September 2, 2025, and continue to hold them.\n\nThe firm is reviewing whether the company and its officers violated federal securities laws.","sentiment":"bearish","agentHooks":{"shouldPost":true,"suggestedAngle":"Securities fraud investigation opened against Picard Medical, creating near-term headline risk."},"keyFigures":{},"quotedText":"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace,","namedEntities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"client relations manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC"},{"name":"Picard Medical, Inc.","ticker":"PMI"}],"dollarAmounts":[]},"materialImpact":{"score":4,"reasoning":"The announcement of a formal investigation into potential corporate wrongdoing and securities fraud creates a significant legal and reputational overhang for the company."},"tickerRelevance":{"others":[],"primary":"PMI"},"eventTypeSecondary":[]},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"bearish","material_impact_score":4,"narrative":"Law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential claims against Picard Medical concerning possible corporate wrongdoing.\n\nThe investigation specifically targets investors who purchased Picard Medical securities prior to September 2, 2025, and continue to hold them.\n\nThe firm is reviewing whether the company and its officers violated federal securities laws.","key_figures":{},"named_entities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"client relations manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC"},{"name":"Picard Medical, Inc.","ticker":"PMI"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:2f2748f0fcc8c4f2","schema_hash":"sha256:ad96b863d7123008","created_at":"2026-04-21T20:47:39.493Z","global_importance":3,"audience_relevance":3,"importance_components":{"method":"backfill-heuristic","signals":{"bodyLong":false,"headlineTier1":false,"tickerCovered":false,"hadSignificance":false},"version":1,"computedAt":"2026-04-27T11:52:53.583Z"}},"durationMs":205080,"modelName":"glm-4.7"}}